Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Eval Program Plann. 2022 Mar 17;92:102070. doi: 10.1016/j.evalprogplan.2022.102070

Table 4.

Model implied estimates for intent-to-treat and as-treated analyses.

Post-Summer Change From Baseline (3-month follow-up) Post-School Change From Baselinea (12-month follow-up)


Pre summer Post-summer Post-School Δ 95CI Difference in Δ 95CI Δ 95CI Difference in Δ 95CI

Intent-to-treat
BMI z-score Control 0.83 0.89 0.91 0.06 (0.01, 0.12) 0.09 (0.01, 0.17)
HSL 0.83 0.86 0.86 0.03 (−0.03, 0.09) −0.03b (−0.11, 0.06) 0.04 (−0.02, 0.14) −0.05b (−0.14, 0.08)
21 C 0.83 0.85 0.87 0.02 (−0.03, 0.08) −0.04c (−0.12, 0.04) 0.04 (−0.03, 0.12) −0.04c (−0.15, 0.07)
MAP Reading Score Control 192.7 193.6 204.8 0.9 (−1.4, 3.2) 12.2 (9.1, 15.2)
HSL 192.4 194.2 204.7 1.8 (−0.5, 4.2) 0.9b (−2.4, 4.2) 12.4 (9.5, 15.3) 0.2b (−4.0, 4.4)
21 C 192.3 193.0 207.2 0.7 (−1.5, 2.8) −0.2c (−3.4, 2.9) 14.9 (12.1, 17.7) 2.7c (−1.4, 6.9)
PACER Laps Control 12.2 12.1 15.6 −0.1 (−1.7, 1.5) 3.4 (−1.7, 1.5)
HSL 12.5 12.3 16.3 −0.1 (−1.8, 1.5) 0.0b (−2.4, 2.3) 3.9 (1.2, 6.5) 0.5b (−3.1, 4.0)
21 C 12.4 13.7 15.7 1.3 (0.3, 2.9) 1.4c (−0.9, 3.6) 3.2 (0.2, 6.2) −0.2c (−4.0, 3.6)
As-treated
BMI z-score Non-attender 0.83 0.91 0.91 0.08 (0.02, 0.14) 0.08 (0.01, 0.16)
Attender 0.83 0.85 0.88 0.02 (−0.02, 0.06) −0.07 (−0.14, 0.01) 0.05 (−0.01, 0.11) −0.03 (−0.12, 0.06)
MAP Reading Score Non-attender 192.3 192.7 205.3 0.4 (−2.1, 1.9) 13.0 (10.6, 16.4)
Attender 192.4 194.9 205.9 2.5 (0.2, 4.8) 2.1 (−4.9, 0.7) 13.5 (11.0, 15.1) 0.5 (−6.1, 8.0)
PACER Laps Non-attender 12.7 13.0 16.9 0.3 (−1.4, 1.9) 4.2 (1.3, 6.5)
Attender 12.9 13.3 17.2 0.5 (−0.7, 1.7) 0.2 (−1.8, 2.2) 4.3 (2.3, 6.4) 0.2 (−3.0, 3.3)

Bolded numbers are statistically significant at p < 0.05.

Abbreviations: “95CI” 95% Confidence Interval, “HSL” Healthy Summer Learners, “21 C” 21st Century Summer Learning Program, “BMI” Body mass index, “MAP” Measures of Academic Progress, “PACER” Progressive Aerobic Cardiovascular Endurance Run.

a

Not collected on the second cohort due to Covid-19 school closures.

b

HSL vs. Control.

c

21 C vs. Control.